TickerFactsScreenerDevelopers

X4 Pharmaceuticals, Inc (XFOR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$21.64M2017: -$21.31M2018: -$25.42M2019: -$48.05M2020: -$58.82M2021: -$70.91M2022: -$77.10M2023: -$96.51M2024: -$130.90M2025: -$85.62M-$85.62M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$85.62M+34.6%
2024-$130.90M-35.6%
2023-$96.51M-25.2%
2022-$77.10M-8.7%
2021-$70.91M-20.5%
2020-$58.82M-22.4%
2019-$48.05M-89.0%
2018-$25.42M-19.3%
2017-$21.31M+1.5%
2016-$21.64M—